Abstract:The chemotherapeutic agent known as 5-fluorouracil (5-FU) is an artificial fluoropyrimidine antimetabolite that has been widely used for its antineoplastic properties. Cocrystals of 5-fluorouracil (5-FU) with five different Schiff bases (benzylidene-urea (BU), benzylidene-aniline (BA), salicylidene-aniline (SA), salicylidene-phenylhydrazine (SPH), and para-hydroxy benzylideneaniline (HBA)) are reported in this study. The newly synthesized cocrystals were analyzed by FTIR and PXRD. In this study, we investigated the antitumor efficacy of 5-FU derivatives in SW480 colon cancer cells via MTT assay at varying dose concentrations. Molecular docking was performed to predict the binding mechanism of TS with various 5-FU complexes. FTIR revealed the presence of respective functional groups in the prepared cocrystals. The frequencies (v) of N-H (3220.24 cm−1) and carbonyl groups (1662.38 cm−1) in the spectrum of 5-FU shifted considerably in all derivative cocrystal new interactions. There was a noticeable transformation in the PXRD peak of 5-FU at 2θ = 28.37° in all derivatives. The novelty of the present study lies in the fact that 5-FU-BA showed an anticancer potential IC50 (6.4731) far higher than that of 5-FU (12.116), almost comparable to that of the reference drug doxorubicin (3.3159), against SW480 cancel cell lines, followed by 5-Fu-HBA (10.2174). The inhibition rates of 5-FU-BA and 5-FU-HBA were highest among the derivatives (99.85% and 99.37%, respectively) in comparison with doxorubicin (97.103%). The results revealed that the synthesized 5-FU cocrystals have promising antitumor efficacy compared with previously reported 5-FU and 5-FU. The activities of the cocrystals were rationalized by a molecular modeling approach to envisage binding modes with the target cancer protein.

Design, Synthesis and Crystal Structure of the Antitumor Agent N1-(2-(4-Methoxy-2-Nitrophenoxy)-2-Dimethyl Acyloxymethyl)-5-Fluorouracil

Synthesis and Crystal Structure of N-1-(2-(4-Bromo-2-Nitrophenoxy)-2-Dimethyl Acyloxymethyl)-5-Fluorouracil

A Second Polymorph of 1-(Carboxymethyl)5-fluorouracil

Synthesis and antitumor activity of N1-acetylamino-(5-alkyl/aryl-1,3,4-thiadiazole-2-yl)-5-fluorouracil derivatives

[Synthesis, Characterization and Antitumor Activity of 5-Fluorouracil-nicotinamide Cocrystal].

Synthesis, Crystal Structure and Antitumor Activity of 4-(5-(2,6-Difluorophenyl)-1,3,4-oxadiazol-2-ylthio)-2-(trifluoromethyl)thieno[2,3-d]pyrimidine

Synthesis of Novel 5-Fluorouracil Derivatives Containing 1,3,4-Thiadiazole and Their Antitumor Activities

[Synthesis of N1-(aryl)alkyloxyacyl-5-fluorouracil Derivatives].

Synthesis of 5- Fluorouracil Derivative and Its Antitumor Activities in Vitro

Synthesis, Spectral Characteristics and Antitumor Activity of Tungstosilicic Polyoxometalate Containing 5-Fluorouracil

A Novel 5-Fluorouracil Salt of 12-Silicatungstic Acid： Synthesis, Structure Characterization and Antitumor Activity

Synthesis, in silico studies, and in vitro biological evaluation of newly-designed 5-amino-1H-tetrazole-linked 5-fluorouracil analog as a potential antigastric-cancer agent.

The Synthesis of 1-Aryl-5-fluorouracil

Synthesis and Anticancer Properties of Tungstosilicic Polyoxometalate Containing 5-Fluorouracil and Neodymium

Synthesis, Structure and Antitumor Activity of Dibutyltin Oxide Complexes with 5-Fluorouracil Derivatives. Crystal Structure of [(5-Fluorouracil)-1-ch2ch2coosn(n-bu) 2]4O2

Synthesis, Structure and Antitumor Activity of Dibutyltin Oxide Complex with 5‐fluorouracil Derivatives

Novel 5-Fluorouracil Derivatives: Synthesis and Cytotoxic Activity of 2-Butoxy-4-substituted 5-Fluoropyrimidines

A 2D Porous Zinc-Organic Framework Platform for Loading of 5-Fluorouracil

Synthesis, Characterization, Theoretical and Experimental Anticancer Evaluation of Novel Cocrystals of 5-Fluorouracil and Schiff Bases against SW480 Colorectal Carcinoma

Synthesis of Novel 5-Fluorouracil Derivatives Containing Amino Acid Schiff Base and Their Antitumor Activities

Synthesis and anticancer properties of rare earth substituted tungstophosphoric polyoxometalate containing 5-fluorouracil